MDS
Clinical trials for MDS explained in plain language.
Never miss a new study
Get alerted when new MDS trials appear
Sign up with your email to follow new studies for MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Tough-to-Treat bone marrow cancer
Disease control Not yet recruitingThis study tests a combination of two drugs, pacritinib and azacitidine, in 25 people with myelodysplastic syndrome (MDS) at moderate to very high risk. The first part finds the safest dose of pacritinib, and the second part checks how well the combo works. Researchers will also …
Matched conditions: MDS
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Not yet recruitingThis study tests whether adding two drugs (SHR2554 and azacitidine) to standard chemotherapy before a stem cell transplant can lower the chance of leukemia returning. It includes 160 people aged 15-60 with high-risk or hard-to-treat acute leukemia or myelodysplastic syndrome. Par…
Matched conditions: MDS
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC